Essential medicines and essential diagnostics: a package deal

被引：15

作者：

Pai, Madhukar ^{[1
,2
,3
]}

Walia, Kamini ^{[4
]}

Boehme, Catharina C. ^{[5
]}

机构：

[1] McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada

[2] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada

[3] Manipal Acad Higher Educ, Manipal McGill Program Infect Dis, Manipal, Karnataka, India

[4] Indian Council Med Res, New Delhi, India

[5] Fdn Innovat New Diagnost, Geneva, Switzerland

来源：

LANCET PUBLIC HEALTH | 2019年 / 4卷 / 10期

关键词：

D O I：

10.1016/S2468-2667(19)30165-3

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：E492 / E492

页数：1

共 6 条

[1]

[Anonymous], 2019, DIAGNOSTICS ARE ESSE

[2] Rethinking assumptions about delivery of healthcare: implications for universal health coverage [J].

Das, Jishnu ;

Woskie, Liana ;

Rajbhandari, Ruma ;

Abbasi, Kamran ;

Jha, Ashish ;

Ki, K. T. .

BMJ-BRITISH MEDICAL JOURNAL, 2018, 361

[3] Essential Diagnostics for the Use of World Health Organization Essential Medicines [J].

Schroeder, Lee F. ;

Guarner, Jeannette ;

Amukele, Timothy K. .

CLINICAL CHEMISTRY, 2018, 64 (08) :1148-1157

[4] The Lancet Commission on diagnostics: advancing equitable access to diagnostics [J].

Wilson, Michael L. ;

Atun, Rifat ;

DeStigter, Kristen ;

Flanigan, John ;

Fleming, Kenneth A. ;

Horton, Susan ;

Kleinert, Sabine ;

Sayed, Shahin .

LANCET, 2019, 393 (10185) :2018-2020

[5]

World Health Organization, 2019, World Health Organization model list of essential medicines: 21st list 2019

[6]

World Health Organization, 2019, 2 WHO MOD LIST ESS I

← 1 →